2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of gamma-secretase.
2,3-Benzodiazepin-1,4-diones were designed as peptidomimetics at the carboxy terminus of hydroxyamides. Inhibition of brain Abeta production was improved by one of the compounds containing constrained modification.